Suppr超能文献

硝苯地平与利托君治疗先兆早产的前瞻性随机试验。

A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor.

作者信息

García-Velasco J A, González González A

机构信息

Department of Obstetrics and Gynecology, La Paz Hospital, Autonoma University, Madrid, Spain.

出版信息

Int J Gynaecol Obstet. 1998 Jun;61(3):239-44. doi: 10.1016/s0020-7292(98)00053-8.

Abstract

OBJECTIVES

To compare the tocolytic efficacy and maternal tolerance of nifedipine with ritodrine in the management of threatened preterm labor.

METHODS

Prospective randomized study of 52 singleton pregnancies with preterm labor between 26 and 34 week's gestation. The capacity to delay delivery 48 h, 7 days, until week 36 or until fetal weight reached 2500 g were the outcome variables assessed. Doppler ultrasound studies were performed on the fetal umbilical artery as control.

RESULTS

No significant differences were found in the delay of delivery, but significantly fewer maternal side-effects were found in the nifedipine group. Doppler ultrasound results were similar in both groups.

CONCLUSIONS

Nifedipine is a valid and well-tolerated alternative among the tocolytic drugs, and apparently does not significantly alter fetal vascular blood flow.

摘要

目的

比较硝苯地平与利托君在治疗先兆早产中的宫缩抑制疗效及母体耐受性。

方法

对52例妊娠26至34周的单胎先兆早产孕妇进行前瞻性随机研究。评估延迟分娩48小时、7天、至36周或直至胎儿体重达到2500克的能力作为结局变量。以胎儿脐动脉多普勒超声检查作为对照。

结果

在延迟分娩方面未发现显著差异,但硝苯地平组的母体副作用明显较少。两组的多普勒超声结果相似。

结论

硝苯地平是宫缩抑制药物中一种有效的且耐受性良好的替代药物,并且显然不会显著改变胎儿血管血流。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验